Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about VIR
Recent news which mentions VIR
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
ACAD
LGND
ONCS
From
Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
Tickers
GSK
MRK
PFE
VIR
Tags
Recent Press Releases
Market News
VIR
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
TBPH
VIR
EPZM
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
ENDP
GILD
FULC
From
Benzinga
GlaxoSmithKline Drops Research On Otilimab In COVID-19
October 27, 2021
Tickers
GSK
VIR
Tags
GSK
Health Care
News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
Tickers
AEZS
AMPL
BFST
BHIL
Tags
BZI/Ratings
Intraday Update
Analyst Ratings
From
Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
Tickers
BAC
BJRI
CCL
MSFT
Tags
OCUL
Analyst Ratings
BAC
From
Benzinga
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
October 23, 2021
Tickers
AZN
GSK
JNJ
LLY
Tags
VIR
Market News
LLY
From
Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
Tickers
ALNY
CELH
GOOG
GOOGL
Tags
GOOG
VIR
Market News
From
Motley Fool
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
Tickers
AZN
AZNCF
GSK
LLY
Tags
COVID/19 Coronavirus
AZN
Phase 3 Trial
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 06, 2021
Tickers
ACER
ADTX
ASMB
AVTX
Tags
UBX
ADTX
EFTR
From
Benzinga
Tesla and Merck Give Investors Some Hope
October 04, 2021
Tickers
GILD
GSK
JNJ
MRK
Tags
Government
Guidance
Benzinga
From
Benzinga
54 Biggest Movers From Friday
October 04, 2021
Tickers
ADGI
ALZN
BHIL
BMRA
Tags
MRVI
Market News
Movers From Yesterday
From
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
Tickers
AVIR
BMRA
NAT
NRBO
Tags
Market News
Oil & Gas Storage & Transportation
SPWR
From
Benzinga
Why a pill you take at home could change the direction of the pandemic
October 01, 2021
Tickers
ADMP
AVIR
GILD
GSK
Tags
AVIR
RDHL
VIR
From
MarketWatch
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
Tickers
ADGI
AVIR
BMRA
CSLT
Tags
BMRA
Top Gainers
QTNT
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
OMIC
BPTS
IBB
From
Benzinga
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
RHHBY
REGN
General
From
Benzinga
Why Vir Biotechnology Stock Is Sinking This Week
September 24, 2021
Tickers
GSK
VIR
Tags
GSK
Market News
VIR
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
Tickers
AHH
AMBA
AXLA
CDTX
Tags
XPOF
FDX
JXN
From
Benzinga
Smart Investors Are Watching This Trend Right Now
September 16, 2021
Tickers
LLY
PFE
REGN
VIR
Tags
PFE
VIR
Market News
From
Motley Fool
Vir Biotechnology Earnings Perspective: Return On Capital Employed
September 06, 2021
Tickers
VIR
Tags
BZI/ROCE
Benzinga
Earnings
From
Benzinga
Now May Be the Big Moment for These 2 COVID Stocks
September 02, 2021
Tickers
GSK
PFE
REGN
VIR
Tags
GSK
REGN
PFE
From
Motley Fool
9 Health Care Stocks With Unusual Options Alerts In Today's Session
August 23, 2021
Tickers
ATNF
CANO
HZNP
MRNA
Tags
HZNP
TRHC
MRNA
From
Benzinga
Vir Biotech-GSK's COVID-19 Treatment Wins Provisional Approval In Australia
August 23, 2021
Tickers
GSK
VIR
Tags
Health Care
Market News
VIR
From
Benzinga
My 2019 Report Card: Up 319%
August 15, 2021
Tickers
AAPL
ADSK
ALTM
AMRN
Tags
DDOG
DIS
SDC
From
Motley Fool
3 Vaccine Stocks for the Next Decade
August 09, 2021
Tickers
BNTX
GSK
MRK
MRNA
Tags
MRNA
Market News
VIR
From
Motley Fool
Earnings Scheduled For August 5, 2021
August 05, 2021
Tickers
TCX
TDC
TDS
TECH
Tags
TDS
UFS
YELP
From
Benzinga
Unusual Options Activity Insight: Vir Biotechnology
July 30, 2021
Tickers
VIR
Tags
Benzinga
VIR
Market News
From
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Tickers
ABCL
ABOS
ACET
ACHL
Tags
ARDS
NXTC
BMRN
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today